Price target of €11.30 constant

In the update to the study on the Geratherm Group published today by AlsterResearch, the upside target of EUR 11.30 can be maintained, despite the rise in energy prices and personnel costs.

Via Research Hub, investors get free access to the update of Geratherm Medical's digital coverage.

Alternatively, you can find the update as a PDF file here.